Michael Mulroy, Director at Lineage Therap, holds 298.56K shares in Lineage Therap (Ticker: LCTX), holds 273.62K shares in Asterias Biotherapeutics (Ticker: AST), holds ― shares in Serina Therapeutics (Ticker: SER). Most recently, Michael Mulroy Bought ― shares of Lineage Therap on Nov 25, 2024 for an estimated value of 22.40K.
What is the percentage of profitable transactions made by Michael Mulroy?
The percentage of profitable transactions made by Michael Mulroy is 50%.
What is the average return per transaction made by Michael Mulroy?
The average return per transaction made by Michael Mulroy is 0.30%.
What stocks does Michael Mulroy hold?
Michael Mulroy holds: LCTX, AST, SER, QCOR stocks.
What was Michael Mulroy’s latest transaction?
Michael Mulroy latest transaction was an Informative Buy of $22.40K.
What was Michael Mulroy's most profitable transaction?
Michael Mulroy’s most profitable transaction was an Informative Buy of LCTX stock on November 25, 2024. The return on the trade was 2.00%.
What is Michael Mulroy's role in Lineage Therap?
Michael Mulroy's role in Lineage Therap is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.